Kwartaalbericht 1e kwartaalmei 2003 Contents

First Page		Document Content
Health Pharmacology Metformin Infliximab Phenformin Anti-diabetic medication Adverse drug reaction Onycholysis Lactic acidosis Medicine Biguanides Guanidines		Kwartaalbericht 1e kwartaalmei 2003 Contents Add to Reading List Source URL: www.lareb.nl Download Document from Source Website File Size: 257,94 KB Share Document on Facebook

	Recall: Riomet™ (Metformin Hydrochloride Oral Solution): Microbial Contamination At PharmPix we are committed to the health and well-being of patients. It is for this reason that we inform that on November 27, 2017 the DocID: 1vpXt - View Document
	Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc DocID: 1tj6K - View Document
	Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc DocID: 1tcHG - View Document
	FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function DocID: 1t6MV - View Document
	Schweizerische Gesellschaft für Endokrinologie und Diabetologie Société Suisse d’Endocrinologie et de Diabétologie Società Svizzera d’Endocrinologia e Diabetologia Societad Svizra d’Endocrinologia e Diabetolog DocID: 1qXHV - View Document